Invisible pollution: The impact of pharmaceuticals in the water supply

AAOHN Journal

Volumn 59, Issue 12, 2011, Pages 525-532

  Strauch, Kimberly A ^a  

^a HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DRUG;

ARTICLE; ENVIRONMENTAL HEALTH; HUMAN; LEGAL ASPECT; NURSING EDUCATION; OCCUPATIONAL HEALTH NURSING; PUBLIC HEALTH; STANDARD; UNITED STATES; WATER POLLUTANT; WATER SUPPLY;

EDUCATION, NURSING, CONTINUING; ENVIRONMENTAL HEALTH; HUMANS; OCCUPATIONAL HEALTH NURSING; PHARMACEUTICAL PREPARATIONS; PUBLIC HEALTH; UNITED STATES; WATER POLLUTANTS, CHEMICAL; WATER SUPPLY;

EID: 84055199768     PISSN: 08910162     EISSN: 19382448     Source Type: Journal    
DOI: 10.3928/08910162-20111123-01     Document Type: Article

References (33)

1. Becker, J., Mendez-Quigley, T., & Phillips, M. (2010). Nursing role in the pharmaceutical life cycle. Nursing Administration Quarterly, 34(4), 297-305.
2. Benotti, M. J., Trenholm, R. A., Vanderford, B. J., Holady, J. C., Stanford, B. D., & Synder, S. A. (2009). Pharmaceuticals and endocrine disrupting compounds in U.S. drinking water. Environmental Science and Toxicology, 43(3), 597-603.
3. Bruce, G. M., Pleus, R. C., & Snyder, S. A. (2010). Toxicological relevance of pharmaceuticals in drinking water. Environmental Science and Technology, 44(14), 5619-5626.
4. Buxton, H. T., & Kolpin, D. W. (2002). Pharmaceuticals, hormones, and other organic wastewater contaminants in U.S. streams, 1999-2000: A national reconnaissance. Environmental Science and Technology, 36(6), 1202-1211. (Pubitemid 34228893)
5. Castensson, S., Eriksson, V., Lindborg, K., & Wettermark, B. (2009). A method to include the environmental hazard in drug prescribing. Pharmacy World and Science, 31, 24-31.
6. Daughton, C. G. (2007). Pharmaceuticals in the environment: Sources and their management. In M. Petrovic & D. Barcelo (Eds.), Analysis, fate and removal of pharmaceuticals in the water cycle (pp. 1-58). Retrieved from www.epa.gov/nerlesd1/bios/daughton/Chap1-Petrovic&Barcelo.pdf
7. Daughton, C. G., & Ruhoy, I. S. (2008). The afterlife of drugs and the role of pharmecovigilance. Drug Safety, 31(12), 1069-1082.
8. Daughton, C. G., & Ruhoy, I. S. (2009). Environmental footprint of pharmaceuticals: The significance of factors beyond direct excretion to sewers. Environmental Toxicology and Chemistry, 28(12), 2495-2521.
9. Donn, J., Mendoza, M., & Pritchard, J. (2008, September 12). AP: Drugs found in drinking water. USA Today. Retrieved from www.usatoday.com/news/ nation/2008-03-10-drugs-tap-water-N.htm
10. Dorne, J. L., Ragas, A. M. J., Frampton, G. K., Spurgeon, D. S., & Lewis, D. F. (2007). Trends in human risk assessment of pharmaceuticals. Analytical and Bioanalytical Chemistry, 387, 1167-1172. (Pubitemid 46220402)
11. Emmanuel, E., Pierre, M. G., & Perrodin, Y. (2009). Groundwater contamination by mircrobiological and chemical substances released from hospital wastewater: Health risk assessment for drinking water consumers. Environment International, 35, 718-726. xs
12. Fent, K., Weston, A. A., & Caminada, D. (2006). Ecotoxicology of human pharmaceuticals. Aquatic Toxicology, 76, 122-159. (Pubitemid 43087657)
13. Fick, J., Lindberg, R. H., Parkkonen, J., Arvidsson, B., Tysklind, M., & Larsson, D. G. (2010). Therapeutic levels of levonorgestrel detected in blood plasma of fish: Results from screening rainbow trout exposed to treated sewage effluents. Environmental Science and Technology, 44(7), 2661-2666.
14. Fick, J., Soderstrom, H., Linderg, R. H., Phan, C., Tysklind, M., & Larsson, D. G. J. (2009). Contamination of surface, ground, and drinking water from pharmaceutical production. Environmental Toxicology and Chemistry, 28(12), 2522-2527.
15. Garrison, A. W., Pope, J. D., & Allen, F. R. (1976). Analysis of organic compounds in domestic wastewater. In C. H. Keith (Ed.), Identification and analysis of organic pollutants in water (pp. 517-556). Ann Arbor, MI: Ann Arbor Science Publishers.
16. Glassmeyer, S. T., Hinchey, E. K., Boehme, S. E., Daughton, C. G., Ruhoy, I. S., Conerly, O., et al. (2009). Disposal practices for unwanted residential medication in the United States. Environment International, 35, 566-572.
17. Jacangelo, J. G., Askenaizer, D. J., & Schwab, K. (2006). Research needs in drinking water: A basis in regulations in the United States. Journal of Water and Health, 4(Suppl. 1), 1-9.
18. Kumar A., Chang, B., & Xagoraraki, I. (2010). Human health risk assessment of pharmaceuticals in water: Issues and challenges ahead. International Journal of Environmental Research and Public Health, 7, 3929-3952.
19. Leal, J. E., Thompson, A. N., & Brzezinski, W. A. (2010). Pharmaceuticals in drinking water: Local analysis of the problem and finding a solution through awareness. Journal of the American Pharmacists Association, 50(5), 600-603.
20. Oaks, J. L., Gilbert, M., Virani, M. Z., Watson, R. T., Meteyer, C. U., Rideout, B. A., et al. (2004). Diclofenac residues as the cause of vulture population decline in Pakistan. Nature, 427(6975), 630-633. (Pubitemid 38248481)
21. Return Unwanted Medicines (RUM) Project. (n.d.). Returning unwanted medicine: The national return and disposal of unwanted medicines limited. Retrieved from www.returnmed.com.au/background
22. Richardson, M. L., & Bowron, J. M. (1985). The fate of pharmaceutical chemicals in the aquatic environment. Journal of Pharmacy and Pharmacology, 37(1), 1-12. (Pubitemid 15189939)
23. Rodriguez-Mozaz, S., & Weinberg, H. S. (2010). Meeting report: Pharmaceuticals in water-An interdisciplinary approach to a public health change. Environmental Health Perspectives, 118(7), 1016-1020.
24. Rogers, I. H., Birtwell, I. K., & Kruznyski, G. M. (1986). Organic extractables in municipal wastewater of Vancouver, British Columbia. Water Pollution Research Journal of Canada, 21, 187-204.
25. Santos, L. H., Araujo, A. N., Fachini, A., Pena, A., Delerue-Matos, C., & Montenegro, M. C. (2009). Ecotoxicological aspects related to the presence of pharmaceuticals in the aquatic environment. Journal of Hazardous Materials, 175(1-3), 45-95.
26. Schwaiger, J., Ferling, H., Mallow, U., Wintermayr, H., & Negele, R. D. (2004). Toxic effects of the non-steroidal anti-inflammatory drug diclofenac: Part I. Histopathological alterations and bioaccumulation in rainbow trout. Aquatic Toxicology, 68(2), 141-150 (Pubitemid 38622488)
27. SMARxT Disposal. (n.d.). SMARxT disposal: A prescription for a healthy planet. Retrieved from www.smarxtdisposal.net
28. U.S. Department of Justice. (2010). National take back initiative. Retrieved from www.deadiversion.usdoj.gov/drug-disposal/takeback/index.html
29. U.S. Environmental Protection Agency. (2010a). Contaminants of emerging concern. Retrieved from http://water.epa.gov/scitech/cec
30. U.S. Environmental Protection Agency. (2010b). Pharmaceuticals and personal care products (PPCPs) in waters. Retrieved from http://water.epa.gov/ scitech/swguidance/ppcp/index.cfm
31. U.S. Environmental Protection Agency. (2010c). Proposed universal waste rule for pharmaceuticals. Retrieved from www.epa.gov/osw/hazard/wastetypes/ universal/pharm-rule.htm
32. U.S. Food and Drug Administration. (2010). Disposal by flushing of certain unused medicines: What you should know. Retrieved from www.fda.gov/Drugs/ResourcesForYou/Consumers/BuyingUsing MedicineSafely/ EnsuringSafeUseofMedicine/SafeDisposalof Medicines/ucm186187. htm#MEDICINES
33. U.S. Geological Survey. (2010). Emerging contaminants in the environment. Retrieved from http://toxics.usgs.gov/regional/emc